Intelligent Bio Solutions Inc (NASDAQ: INBS)’s stock price has plunge by -19.32relation to previous closing price of 2.64. Nevertheless, the company has seen a -14.46% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-20 that NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of its previously announced underwritten public offering of 1,304,348 shares of common stock at a public offering price of $2.00 per share of common stock, for gross proceeds of approximately $2.6 million, before deducting underwriting discounts and commissions and offering expenses.
Is It Worth Investing in Intelligent Bio Solutions Inc (NASDAQ: INBS) Right Now?
Company’s 36-month beta value is 4.76.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INBS is 5.18M, and currently, short sellers hold a 8.43% ratio of that floaft. The average trading volume of INBS on February 20, 2025 was 188.83K shares.
INBS’s Market Performance
INBS stock saw an increase of -14.46% in the past week, with a monthly gain of 45.89% and a quarterly increase of 43.92%. The volatility ratio for the week is 15.24%, and the volatility levels for the last 30 days are 11.02% for Intelligent Bio Solutions Inc (INBS). The simple moving average for the past 20 days is 10.33% for INBS’s stock, with a 25.24% simple moving average for the past 200 days.
INBS Trading at 30.99% from the 50-Day Moving Average
After a stumble in the market that brought INBS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.17% of loss for the given period.
Volatility was left at 11.02%, however, over the last 30 days, the volatility rate increased by 15.24%, as shares surge +54.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.96% upper at present.
During the last 5 trading sessions, INBS fell by -13.10%, which changed the moving average for the period of 200-days by -18.65% in comparison to the 20-day moving average, which settled at $1.93. In addition, Intelligent Bio Solutions Inc saw 52.14% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for INBS
Current profitability levels for the company are sitting at:
- -3.58 for the present operating margin
- 0.41 for the gross margin
The net margin for Intelligent Bio Solutions Inc stands at -3.53. The total capital return value is set at -2.53. Equity return is now at value -279.80, with -122.18 for asset returns.
Based on Intelligent Bio Solutions Inc (INBS), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -16.17. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -81.46.
Currently, EBITDA for the company is -8.81 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 3.14. The receivables turnover for the company is 11.39for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
In a nutshell, Intelligent Bio Solutions Inc (INBS) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
